PMV Pharmaceuticals Inc’s Market Journey: Closing Strong at 2.18, Up 3.81

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The closing price of PMV Pharmaceuticals Inc (NASDAQ: PMVP) was $2.18 for the day, up 3.81% from the previous closing price of $2.10. In other words, the price has increased by $3.81 from its previous closing price. On the day, 0.74 million shares were traded. PMVP stock price reached its highest trading level at $2.21 during the session, while it also had its lowest trading level at $2.065.


Our analysis of PMVP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.78 and its Current Ratio is at 14.78. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on April 12, 2024, initiated with a Buy rating and assigned the stock a target price of $5.

On December 27, 2023, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.

Oppenheimer Upgraded its Perform to Outperform on March 02, 2022, while the target price for the stock was maintained at $30.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 22 ’23 when ORBIMED ADVISORS LLC sold 87,786 shares for $2.23 per share. The transaction valued at 195,763 led to the insider holds 0 shares of the business.

Alland Leila sold 6,291 shares of PMVP for $41,646 on Sep 15 ’23. The Chief Medical Officer now owns 45,909 shares after completing the transaction at $6.62 per share. On Sep 15 ’23, another insider, Jalota Deepika, who serves as the Chief Development Officer of the company, sold 4,104 shares for $6.62 each. As a result, the insider received 27,168 and left with 29,946 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 112146832 and an Enterprise Value of -77624200.

Stock Price History:

Over the past 52 weeks, PMVP has reached a high of $9.72, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is 25.96%, while the 200-Day Moving Average is calculated to be -34.85%.

Shares Statistics:

PMVP traded an average of 599.91K shares per day over the past three months and 516790 shares per day over the past ten days. A total of 51.45M shares are outstanding, with a floating share count of 40.71M. Insiders hold about 20.87% of the company’s shares, while institutions hold 88.02% stake in the company. Shares short for PMVP as of 1713139200 were 2781533 with a Short Ratio of 4.64, compared to 1710460800 on 2258313. Therefore, it implies a Short% of Shares Outstanding of 2781533 and a Short% of Float of 6.35.

Most Popular

[the_ad id="945"]